On this page
Baloxavir Marboxil
Active ingredient 3 prescription 2 with labelling
Overview
Source: NDC DirectoryIngredient name
BALOXAVIR MARBOXIL
Base moiety
BALOXAVIR MARBOXIL
RxNorm CUI
UNII
505CXM6OHG
Medication products
7
Brand names
1
Dosage forms
6
FAERS reports
2,301 · not a risk measure
- BALOXAVIR MARBOXIL Baloxavir Marboxil · Tablet
- Baloxavir marboxil Powder
- Baloxavir marboxil Granule, for Suspension
- Baloxavir marboxil Tablet, Coated
- Xofluza Baloxavir Marboxil · Granule, for Solution
- Xofluza Baloxavir Marboxil · Tablet, Film Coated
- Xofluza Baloxavir Marboxil · Granule, for Suspension
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| GRANULE, For Suspension | 2 | Baloxavir marboxil, Xofluza |
| Tablet | 1 | BALOXAVIR MARBOXIL |
| Powder | 1 | Baloxavir marboxil |
| TABLET, Coated | 1 | Baloxavir marboxil |
| GRANULE, For Solution | 1 | Xofluza |
| TABLET, Film Coated | 1 | Xofluza |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |